and automated batch processing can all assist in helping labs respond to issues as quickly and efficiently as possible. Supply chain challenges take many forms in pharma – from capacity issues ...

In times of accelerated process design, pharma companies must drop manual workflows that risk clerical errors and data integrity violations. Digital batch execution management, electronic lab ...

Dublin, May 09, 2025 (GLOBE NEWSWIRE) -- The "Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech ... Strategic Case Studies & Deal Analysis - Examine real-world deal ...

The Kano State Pilgrims Welfare Board has announced that the first batch of the 2025 pilgrims to Saudi Arabia will commence in a few weeks, saying preparation has been concluded. Director-General ...

The industry’s reputation surged during the COVID-19 pandemic, according to PatientView’s annual survey of patient groups, peaking two years ago, when 60% of those surveyed said pharma’s ...

SINGAPORE/SHANGHAI (Reuters) -A wave of dollar selling in Asia is an ominous sign for the greenback as the world's export powerhouse starts to question a decades-long trend of investing its big ...

today announced it has raised $3.6 million in new funding to accelerate growth and scale adoption of its enterprise-grade platform among global pharma companies. The round includes participation ...

Trump’s threat of pharma tariffs marks a fresh development in the president’s aggressive trade agenda. On Sunday, he threatened to impose 100% tariffs on foreign-made films. (Ambar Warrick ...

NEW DELHI – A drone strike hit the Kyiv warehouse of Indian pharmaceutical giant Kusum, Ukraine said on April 12, alleging that Russia deliberately targeted Indian-owned businesses. The attack ...

U.S.-listed shares of GSK are gaining in intraday trading Wednesday after the British pharma giant posted better-than-expected first-quarter results and said it was "well positioned" should the ...

It builds upon a previous analysis that STAT published prior to ... advocates insist. “Pharma is fighting us hard in any way that they can: By campaign contributions, by lobbying, whatever ...

Another Big Pharma is opening up its wallet to pour billions into its U.S. operations amid political pressure from the Trump administration. This time it’s Gilead coming to the table with a ...